• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

BCBS Kansas City to Offer Livongo for Diabetes Program to All Fully Insured Clients

by Fred Pennic 10/17/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

UCSF Launches SUGAR Clinical Trial Study to Compare Livongo’s Diabetes Management Program to Standard Diabetes Care

– Livongo announced an expanded partnership with Blue Cross and Blue Shield of Kansas City to provide Livongo for Diabetes program to all Blue KC fully insured clients.

– Blue KC was an early Livongo adopter and this expansion provides momentum as we continue to expand from working primarily with self-insured employers to broader markets including fully insured populations of our health plan clients.

Livongo Health, Inc. (Nasdaq: LVGO), an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, announced that it has expanded its partnership with Blue Cross and Blue Shield of Kansas City (Blue KC) to offer the Livongo for Diabetes program to all Blue KC fully insured clients. In addition, Livongo is now available to eligible Blue KC Administrative Services Only (ASO) clients.

The Livongo for Diabetes program is a whole person platform focused on empowering members with education and tools to self-manage their diabetes through mobile technology. The program offers members a cellular-enabled, two-way messaging device that measures blood glucose and delivers personalized insights, free unlimited supplies, and access to Certified Diabetes Educators for instant support and goal setting.

Livongo for Diabetes Program Results for Blue KC Clients

To date, Blue KC clients using Livongo demonstrated a combined +75 NPS score and a significant decrease in eHbA1c. Blue KC is the largest not-for-profit health insurer in Missouri, the only not-for-profit commercial health insurer in Kansas City, and provides health coverage services to more than one million members.

More than 720 organizations, including more than 20 percent of the Fortune 500 self-insured employers, health systems, health plans, and the two leading pharmacy benefit managers have implemented Livongo solutions.

Why It Matters for Blue KC Clients & Plan Members

“As the chronic condition epidemic in the United States continues to progress, it is paramount that healthcare organizations find solutions that address these conditions and the related costs,” said Raelene Knolla, D.O., Department Vice President and Senior Medical Director for Blue KC. “Through a combination of technology, data science, and coaching, Livongo has proven its effectiveness in delivering a great experience that bends the cost curve for organizations who provide health coverage services. We are excited for our continued work together and for the prospects of improved outcomes and cost savings for our Clients and Members.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Applied Health Signals, diabetes, digital diabetes management platform, Digital Diabetes Platform, Health Systems, Livongo, Livongo Health, Pharmacy

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |